CCR2 and neoplasm: As a result, the ability of CCR2 + IM to decrease CD8 + T cells and increase regulatory T-cells (CD4 + , FoxP3 + , CD25 +) may be a potential mechanism for its promotion of tumor growth at the metastatic site.